Nathan Merki is currently the Associate Director - Lead Neuroscience Forecaster at Eli Lilly and Company, where they lead forecasting activities for US Migraine assets and Alzheimer’s therapeutics. Previously, they held various roles at Eli Lilly, including Global Demand Consultant and Consultant for Diabetes Connected Care Forecasting. Nathan's early career includes experience as a Supply Chain Specialist at Arvin Meritor and several management roles at Olivet Nazarene University. Nathan holds a BS in Business Administration, Economics, and Finance, as well as an MBA from Olivet Nazarene University.
This person is not in any teams
This person is not in any offices